Literature DB >> 10799162

Limitations of computerized tomography in staging invasive bladder cancer before radical cystectomy.

M L Paik1, M J Scolieri, S L Brown, J P Spirnak, M I Resnick.   

Abstract

PURPOSE: Computerized tomography (CT) of the abdomen and pelvis is often routine in the preoperative staging assessment of invasive transitional cell carcinoma of the bladder. We determine the accuracy of staging CT findings, usefulness before planned extirpative surgery and impact on surgical management of this disease.
MATERIALS AND METHODS: We retrospectively reviewed the medical records, including radiographic, operative and pathological reports, of 82 consecutive cases. All patients presented with muscle invasive bladder tumors, were considered candidates for radical cystectomy and underwent preoperative staging CT of the abdomen and pelvis between July 1994 and June 1998. The ability of CT to provide additional staging information in terms of depth of tumor invasion, local extent of tumor, pelvic lymph node involvement and distant metastases was examined. We determined whether CT findings altered surgical management for individual patients.
RESULTS: CT was able to discriminate depth of invasion in only 1 patient (1.2%) and correctly identified extravesical tumor spread in 4 (4.9%). Lymph node and distant metastases were accurately determined in 4 (4.9%) and 2 (2.4%) cases, respectively. The overall accuracy of CT was 54. 9%, with an under staging and over staging rate of 39.0% and 6.1%, respectively. CT provided accurate, additional staging information in only 8 cases (9.8%). Surgical management was altered in 3 cases (3.7%) and only 1 (1.2%) avoided an unnecessary operation as a result of CT findings.
CONCLUSIONS: Staging CT of the abdomen and pelvis in patients with invasive bladder carcinoma has limited accuracy, mainly because of its inability to detect microscopic or small volume extravesical tumor extension and lymph node metastases. CT tends to under stage advanced disease and failed to alter surgical management in nearly all of our cases.

Entities:  

Mesh:

Year:  2000        PMID: 10799162

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  46 in total

Review 1.  Preoperative imaging for staging bladder cancer.

Authors:  Maxim J McKibben; Michael E Woods
Journal:  Curr Urol Rep       Date:  2015-04       Impact factor: 3.092

Review 2.  [The role of pelvic lymphadenectomy in clinically localised prostate cancer].

Authors:  M Schumacher; F C Burkhard; U E Studer
Journal:  Urologe A       Date:  2005-06       Impact factor: 0.639

Review 3.  Staged based directed surveillance of invasive bladder cancer following radical cystectomy: valuable and effective?

Authors:  S Machele Donat
Journal:  World J Urol       Date:  2006-11       Impact factor: 4.226

4.  Diagnostic value of [18F] FDG-PET and PET/CT in urinary bladder cancer: a meta-analysis.

Authors:  Huojun Zhang; Wei Xing; Qinqin Kang; Chao Chen; Linhui Wang; Jianping Lu
Journal:  Tumour Biol       Date:  2015-03-26

5.  Should we spare neoadjuvant chemotherapy in low-risk muscle-invasive bladder cancer patients scheduled for radical cystectomy?

Authors:  Günter Niegisch
Journal:  Transl Androl Urol       Date:  2019-07

6.  Comparative sensitivity and specificity of imaging modalities in staging bladder cancer prior to radical cystectomy: a systematic review and meta-analysis.

Authors:  Jack Crozier; Nathan Papa; Marlon Perera; Brian Ngo; Damien Bolton; Shomik Sengupta; Nathan Lawrentschuk
Journal:  World J Urol       Date:  2018-08-17       Impact factor: 4.226

7.  Clinical value of fluorine-18 2-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography in bladder cancer.

Authors:  Andrea B Apolo; Jamie Riches; Heiko Schöder; Oguz Akin; Alisa Trout; Matthew I Milowsky; Dean F Bajorin
Journal:  J Clin Oncol       Date:  2010-08-02       Impact factor: 44.544

Review 8.  Diagnostic accuracy of C-11 choline and C-11 acetate for lymph node staging in patients with bladder cancer: a systematic review and meta-analysis.

Authors:  Seong-Jang Kim; Phillip J Koo; Kyoungjune Pak; In-Ju Kim; Keunyoung Kim
Journal:  World J Urol       Date:  2018-01-02       Impact factor: 4.226

9.  FDG-PET for preoperative staging of bladder cancer.

Authors:  O Drieskens; R Oyen; H Van Poppel; Y Vankan; P Flamen; L Mortelmans
Journal:  Eur J Nucl Med Mol Imaging       Date:  2005-08-31       Impact factor: 9.236

10.  Adjuvant chemotherapy is associated with decreased mortality after radical cystectomy for locally advanced bladder cancer.

Authors:  Daniel A Yelfimov; Igor Frank; Stephen A Boorjian; Prabin Thapa; John C Cheville; Matthew K Tollefson
Journal:  World J Urol       Date:  2014-01-14       Impact factor: 4.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.